Literature DB >> 17099250

Identification of a region of troponin I important in signaling cross-bridge-dependent activation of cardiac myofilaments.

Patti L Engel1, Tomoyoshi Kobayashi, Brandon Biesiadecki, Jonathan Davis, Svetlana Tikunova, Steven Wu, R John Solaro.   

Abstract

Force generating strong cross-bridges are required to fully activate cardiac thin filaments, but the molecular signaling mechanism remains unclear. Evidence demonstrating differential extents of cross-bridge-dependent activation of force, especially at acidic pH, in myofilaments in which slow skeletal troponin I (ssTnI) replaced cardiac TnI (cTnI) indicates the significance of a His in ssTnI that is an homologous Ala in cTnI. We compared cross-bridge-dependent activation in myofilaments regulated by cTnI, ssTnI, cTnI(A66H), or ssTnI(H34A). A drop from pH 7.0 to 6.5 induced enhanced cross-bridge-dependent activation in cTnI myofilaments, but depressed activation in cTnI(A66H) myofilaments. This same drop in pH depressed cross-bridge-dependent activation in both ssTnI myofilaments and ssTnI(H34A) myofilaments. Compared with controls, cTnI(A66H) myofilaments were desensitized to Ca(2+), whereas there was no difference in the Ca(2+)-force relationship between ssTnI and ssTnI(H34A) myofilaments. The mutations in cTnI and ssTnI did not affect Ca(2+) dissociation rates from cTnC at pH 7.0 or 6.5. However, at pH 6.5, cTnI(A66H) had lower affinity for cTnT than cTnI. We also probed cross-bridge-dependent activation in myofilaments regulated by cTnI(Q56A). Myofilaments containing cTnI(Q56A) demonstrated cross-bridge-dependent activation that was similar to controls containing cTnI at pH 7.0 and an enhanced cross-bridge-dependent activation at pH 6.5. We conclude that a localized N-terminal region of TnI comprised of amino acids 33-80, which interacts with C-terminal regions of cTnC and cTnT, is of particular significance in transducing signaling of thin filament activation by strong cross-bridges.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099250     DOI: 10.1074/jbc.M512337200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation.

Authors:  R John Solaro; Paul Rosevear; Tomoyoshi Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

2.  Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.

Authors:  Katherine A Sheehan; Grace M Arteaga; Aaron C Hinken; Fernando A Dias; Cibele Ribeiro; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-11-01       Impact factor: 5.000

3.  Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity.

Authors:  Ying H Lin; William Schmidt; Kristofer S Fritz; Mark Y Jeong; Anthony Cammarato; D Brian Foster; Brandon J Biesiadecki; Timothy A McKinsey; Kathleen C Woulfe
Journal:  J Mol Cell Cardiol       Date:  2020-01-22       Impact factor: 5.000

Review 4.  Cardiac thin filament regulation.

Authors:  Tomoyoshi Kobayashi; Lei Jin; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2008-04-18       Impact factor: 3.657

5.  Tropomyosin Ser-283 pseudo-phosphorylation slows myofibril relaxation.

Authors:  Benjamin R Nixon; Bin Liu; Beatrice Scellini; Chiara Tesi; Nicoletta Piroddi; Ozgur Ogut; R John Solaro; Mark T Ziolo; Paul M L Janssen; Jonathan P Davis; Corrado Poggesi; Brandon J Biesiadecki
Journal:  Arch Biochem Biophys       Date:  2012-12-08       Impact factor: 4.013

6.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

Review 7.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

8.  Ca++-sensitizing mutations in troponin, P(i), and 2-deoxyATP alter the depressive effect of acidosis on regulated thin-filament velocity.

Authors:  Thomas J Longyear; Matthew A Turner; Jonathan P Davis; Joseph Lopez; Brandon Biesiadecki; Edward P Debold
Journal:  J Appl Physiol (1985)       Date:  2014-03-20

9.  Significance of troponin dynamics for Ca2+-mediated regulation of contraction and inherited cardiomyopathy.

Authors:  Devanand Kowlessur; Larry S Tobacman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

Review 10.  Sarcomere control mechanisms and the dynamics of the cardiac cycle.

Authors:  R John Solaro
Journal:  J Biomed Biotechnol       Date:  2010-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.